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The major objective of the present study was to identify biologic and behavioral risk factors of cardiovascular
disease (CVD) in the elderly population in Taiwan. It is hypothesized that the selected risk factors are
significantly associated with the prevalence of CVD. Data came from a nationwide geriatric survey in
1991. Stratified proportional sampling was used to recruit 2,600 subjects. These were evaluated by family
physicians working for the Departments of Family Medicine at four medical centers in four major cities
in Taiwan. Univariate and multivariate logistic regression analyses were used to examine the associations
between risk factors and the prevalence of CVD. The prevalence of CVD was 38.31%. Patients with CVD
consistently had higher values for each selected risk factor except high-density lipoprotein-cholesterol
(HDL-C) and glucose concentrations. The findings also indicated that hypertension, hypertriglyceridemia,
low HDL-C concentration, ex-drinking status, and overweight were significantly associated with the
prevalence of CVD among the elderly in Taiwan. The findings not only confirm the risk factors for CVD,
but also invite more attention to be given to the importance of biologic and behavioral risk factors in CVD.
Key Words: cardiovascular disease, risk factors, elderly, prevalence
(Kaohsiung J Med Sci 2004;20:279–86)
Received: December 26, 2003     Accepted: April 2, 2004
Address correspondence and reprint requests to: Dr. Yong-Yuan
Chang, Graduate Institute of Public Health, Kaohsiung Medical
University, 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan.
E-mail: m685001@kmu.edu.tw
© 2004 Elsevier. All rights reserved.
The lifestyle in Taiwan has changed dramatically with
recent rapid economic growth. Consequently, the major
causes of mortality have changed from infectious diseases
to chronic diseases. Among chronic diseases, heart di-
sease is life-threatening and was ranked as the third lead-
ing cause of death in Taiwan in 1991. The mortality rate
for heart disease increased from 37.38 per 100,000 in 1988
to 41.75 per 100,000 in 1991 [1]. The prevalence of heart di-
sease increases with age, especially for coronary heart di-
sease (CHD) [2,3]. In Taiwan, the proportion of people aged
65 years and over reached 7.8% in 1997 [4]. Developing effec-
tive and efficient prevention and treatment programs for
cardiovascular disease (CVD) has been a major focus of
public health and clinical research.
To identify the determinants of CVD for health services
planning, many epidemiologic studies have focused on the
influence of specific biologic factors, whereas others have
examined behavioral and lifestyle factors. However,
information on the risk factors for CVD and their prevalence
among the elderly in Taiwan is limited.
The first community-based study of the prevalence of
heart disease in Taiwan was conducted by Tsai et al in 1965
using a cross-sectional design in a small rural aborigine
township in central Taiwan [3]. Later studies contributed
information on the prevalence of heart disease, especially
CHD, which ranged from 3.1% to 3.5% without significant
variation [5–7]. However, epidemiologic studies limited
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samples to residents of northern Taiwan and only focused
on the general population. The prevalence of CHD in Tai-
wan was similar to those in other Asian countries [8], and al-
most 50% less than the prevalence in Western countries
[9–11]. The prevalence of other types of heart disease, such
as hypertensive CVD (HCVD), has not been examined in
Taiwan. The measurement of various manifestations is not
easy, so the present study focused on the prevalence of total
CVD.
The association of biologic risk factors with CVD
has been studied extensively in developed countries.
Hypertension, hypercholesterolemia, low high-density
lipoprotein-cholesterol (HDL-C) concentration, high low-
density lipoprotein-cholesterol (LDL-C) concentration,
hypertriglyceridemia, and diabetes mellitus are well
established determinants of CVD [8,10,12–17]. Although
similar findings were found in several studies in Taiwan
[18–22], most studies confined their samples to the hospi-
tal setting or did not focus on community elderly.
In addition to biologic risk factors for CVD, increas-
ing attention is called to behavioral risk factors. Many
epidemiologic studies have demonstrated positive
associations between alcohol intake, smoking, physical
inactivity, and obesity with the prevalence of CVD [14,17,
23–27]. There is a positive association between heavy
drinking and the prevalence of CVD [25–27], although
several studies have reported that light to moderate alcohol
intake can provide protection against CVD [2,27,28]. In
Taiwan, not much effort has been made to study behavioral
risk factors for CVD, particularly focusing on the elderly
population.
The major aim of the present study was to identify
biologic and behavioral risk factors for CVD among the
elderly in Taiwan based on the data collected by the
nationwide geriatric epidemiologic survey in 1991 [29].
MATERIALS AND METHODS
Sample and data
Data were derived from a nationwide geriatric survey
funded by the Department of Health, Taiwan, in 1989–1991.
The nationwide survey was conducted by the Departments
of Internal Medicine and Family Medicine of three medical
centers and one regional hospital in four major cities in
Taiwan: Taipei, Taichung, Kaohsiung, and Hualien. The
original purpose of the geriatric epidemiologic study was to
evaluate the lifestyle, disease patterns, and health status
of community elderly aged at least 65 years. Stratified
proportional sampling was used to recruit the sample. The
response rates for each geographic area were as follows:
northern areas, 48.9%; central areas, 37.3%; southern areas,
63.1%; and eastern areas, 47.9%.
Sampled subjects were invited to the designated medi-
cal centers for a comprehensive health status examination
combined with physical, neurologic, and laboratory evalua-
tions [29]. At the same time, a questionnaire was admin-
istered by physicians to assess medical history, alcohol
consumption, and cigarette smoking. Home visits and as-
sessments were arranged for subjects with transportation
problems. A total of 1,417 subjects were included in northern
Taiwan, 400 in central Taiwan, 500 in southern Taiwan, and
283 in eastern Taiwan. A total of 2,600 subjects who com-
pleted the survey between April 1989 and June 1991 served
as the data source for the present study.
Validity and reliability of data
To enhance the validity and reliability of the data, National
Taiwan University Hospital (NTUH) served as the quality
control center. To control the technical equipment and
operational procedures, all the laboratory, X-ray, and
electrocardiogram (ECG) samples were delivered to NTUH
for examination and interpretation. Blood samples collected
in other designated medical centers were delivered to NTUH
on the day of collection. ECGs were examined by two
professors using the same established criteria. Therefore,
variations in the results from sample to sample were assumed
to be minimized.
Measurement
Different types of CVD were included in the present study:
HCVD, CHD (i.e. angina pectoris and myocardial infarc-
tion), cardiac dysrhythmias, rheumatic heart disease,
heart failure, and other heart diseases. To be classified in the
CVD group, subjects had to meet the following criteria.
First, subjects with self-reported heart problems were
confirmed by history from medical records. Second, subjects
with self-reported heart problems but no CVD medical
history were confirmed by ECG changes. Finally, subjects
with at least one of the listed heart diseases were included
in the CVD group, while all other subjects were considered
to be in the non-CVD group for further analyses.
The normality thresholds for the examined risk factors
are presented in Table 1, grouped into biologic and behav-
ioral factors. Hypertension, hypercholesterolemia, low
HDL-C concentration, high LDL-C concentration, hypertri-
glyceridemia, and diabetes mellitus were considered bio-
logic (biochemical) factors or clinical parameters. For the
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behavioral or lifestyle factors, heavy smoker, ex-smoker,
and overweight were examined. Subjects who had quit
smoking more than 6 months previously were considered
ex-smokers. Body mass index (BMI) was used to measure
overweight: a subject with a BMI of at least 25 was included
as overweight.
In addition to biologic and behavioral factors, the
literature evidence indicates that gender and age also affect
CVD prevalence [30,31]. Therefore, gender and age were
used as control variables for further multivariate analyses.
Statistical analysis
Descriptive analysis and correlation were used to under-
stand the distributions of the selected risk factors for
CVD. Both univariate and multivariate logistic regression
analyses were performed to evaluate the pure effect of
each risk factor and the simultaneous influences of the
risk factors on the prevalence of CVD, as some researchers
have suggested that univariate analysis is as important
as multivariate analysis [32].
RESULTS
Subjects were divided into CVD and non-CVD groups for
Table 1. Definitions of cardiovascular disease risk factors
Definition
Biologic risk factor
Hypertension SBP ≥ 160 mmHg or
DBP ≥ 95 mmHg or
Use of any antihypertensive drugs
on a regular basis
Hypercholesterolemia Fasting serum cholesterol
≥ 240 mg/dL
Hypertriglyceridemia TG ≥ 200 mg/dL
Low HDL-C HDL-C < 35 mg/dL
High LDL-C LDL-C ≥ 160 mg/dL
Diabetes Fasting serum glucose ≥ 140 mg/dL or
Treatment with oral hypoglycemic
drug or insulin
Behavioral risk factor
Heavy smoker ≥ 20 cigarettes/day
Ex-smoker Quit smoking for > 6 months
Overweight BMI ≥ 25 kg/m2
SBP = systolic blood pressure; DBP = diastolic blood pressure; TG =
triglyceride; HDL-C = high-density lipoprotein-cholesterol; LDL-C =
low-density lipoprotein-cholesterol; BMI = body mass index.
Table 2. Comparison of risk factors for cardiovascular disease (CVD) between subjects with and without CVD
CVD group Non-CVD group
n Mean SD n Mean SD
Continuous risk factor
Age, yr 697 71.13 4.24 1,849 71.42 4.56
SBP, mmHg 683 153.42 20.86 1,816 139.22 20.18
DBP, mmHg 684 86.89 11.69 1,817 80.45 10.63
Cholesterol, mg/dL 672 208.68 42.57 1,802 203.23 42.04
LDL-C, mg/dL 567 124.10 42.22 1,572 120.60 41.63
HDL-C, mg/dL 572 43.87 16.27 1,585 46.49 16.76
Triglyceride, mg/dL 670 140.51 79.92 1,797 118.25 73.40
Glucose, mg/dL 617 124.00 52.67 1,659 124.18 57.58
BMI, kg/m2 666 24.75 3.43 1,783 23.69 3.56
n (%) n (%)
Categorical risk factor
Male gender 352 (46.87) 970 (52.46)
Ex-smoker 40 (5.33) 76 (4.11)
Heavy smoker 92 (12.25) 278 (15.04)
Prevalence 996 (38.31) 1,604 (61.69)
SD = standard deviation; SBP = systolic blood pressure; DBP = diastolic blood pressure; LDL-C = low-density lipoprotein-cholesterol; HDL-
C = high-density lipoprotein-cholesterol; BMI = body mass index.
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descriptive analyses. The distributions of continuous risk
variables are presented in Table 2. The mean age in the two
groups was similar: 71.13 ± 4.24 years in the CVD group and
71.42 ± 4.56 years in the non-CVD group. The CVD group
consistently had a higher value for each variable except
HDL-C and glucose concentrations. A higher percentage of
female subjects and ex-smokers were also found in the CVD
group. In total, the prevalence of CVD was 38.31% (n = 996).
Table 3 presents the results of univariate logistic re-
gression analysis. Gender, but not age, had a significant
association with the prevalence of CVD. Male subjects were
less likely to have CVD compared with female subjects
(odds ratio, OR = 0.80; 95% confidence interval, 95% CI,
0.67, 0.95). Subjects with hypertension were 6.54 times more
likely to have CVD than subjects with normal blood pres-
sure (95% CI, 5.40, 7.92). Subjects with hypercholesterole-
mia were 27% more likely to have CVD than subjects with
normal cholesterol (95% CI, 1.02, 1.59). Subjects with
hypertriglyceridemia were almost twice as likely to have
CVD as subjects with triglycerides in the normal range (95%
CI, 1.51, 2.56). Subjects with lower HDL-C concentrations
were 36% more likely to have CVD compared with subjects
who had higher concentrations. By the same token, subjects
with high LDL-C concentrations were 32% more likely to
have CVD. However, diabetes mellitus was not significantly
associated with the prevalence of CVD.
Overweight was significantly associated with the pre-
valence of CVD (OR = 1.54; 95% CI, 1.29, 1.85). Yet, smok-
ing behavior, either ex-smokers or heavy smokers, did
not have a significant impact on the prevalence of CVD.
The results of multivariate logistic regression analysis
are presented in Table 4. After controlling for gender and
Table 3. Univariate logistic regression analysis of cardiovascular disease in the elderly in Taiwan
Risk factor Parameter estimate p Odds ratio 95% CI (lower, upper)
Gender (female = 0) –0.21 0.015 0.80 0.67, 0.95
Age (yr) –0.01 0.150 0.98 0.96, 1.00
Hypertension (no = 0) 1.87 0.000 6.54 5.40, 7.92
Hypercholesterolemia (no = 0) 0.24 0.031 1.27 1.02, 1.59
Hypertriglyceridemia (no = 0) 0.67 0.000 1.97 1.51, 2.56
Low HDL-C (HDL-C ≥ 35 mg/dL = 0) 0.30 0.004 1.36 1.10, 1.68
High LDL-C (LDL-C < 160 mg/dL = 0) 0.28 0.029 1.32 1.02, 1.70
Diabetes mellitus (no = 0) –0.09 0.386 0.90 0.72, 1.13
Ex-smoker (no = 0) 0.23 0.248 1.27 0.84, 1.90
Heavy smoker (no = 0) –0.17 0.174 0.83 0.64, 1.08
Overweight (BMI < 25 = 0) 0.43 0.000 1.54 1.29, 1.85
CI = confidence interval; HDL-C = high-density lipoprotein-cholesterol; LDL-C = low-density lipoprotein-cholesterol; BMI = body mass index.
Table 4. Multivariate logistic regression analysis of cardiovascular disease in the elderly in Taiwan
Risk factor Parameter estimate p Odds ratio 95% CI (lower, upper)
Intercept –1.32 0.128
Gender (female = 0) –0.14 0.231 0.87 0.69, 1.09
Age (yr) –0.01 0.461 0.99 0.97, 1.01
Hypertension (no = 0) 1.86 0.000 6.45 4.51, 7.95
Hypercholesterolemia (no = 0) –0.00 0.993 1.00 0.70, 1.43
Hypertriglyceridemia (no = 0) 0.41 0.012 1.50 1.09, 2.06
Low HDL-C (HDL-C ≥ 35 mg/dL = 0) 0.27 0.027 1.31 1.03, 1.66
High LDL-C (LDL-C < 160 mg/dL = 0) 0.21 0.266 1.23 0.86, 1.77
Diabetes mellitus (no = 0) –0.05 0.702 0.95 0.73, 1.24
Ex-smoker (no = 0) 0.52 0.058 1.68 0.98, 2.87
Heavy smoker (no = 0) –0.22 0.216 0.80 0.56, 1.14
Overweight (BMI < 25 = 0) 0.24 0.128 1.27 1.02, 1.57
The overall fit of the model was evaluated by log likelihood ratio: χ2 = 392.091 with 11 degrees of freedom, p = 0.0001. CI = confidence interval;
HDL-C = high-density lipoprotein-cholesterol; LDL-C = low-density lipoprotein-cholesterol; BMI = body mass index.
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age, three of six biologic factors were significantly associated
with the prevalence of CVD. Subjects with hypertension
were 6.45 times more likely to have CVD than normotensive
subjects (95% CI, 4.51, 7.95). Subjects with hypertrigly-
ceridemia were 50% more likely to have CVD than subjects
with normal triglyceride levels (95% CI, 1.09, 2.06). The
elderly with low HDL-C concentrations were 31% more
likely to have CVD compared to elderly with higher con-
centrations (95% CI, 1.03, 1.66). Hypercholesterolemia and
high LDL-C concentrations were significant predictors
in the univariate analysis, but not in the multivariate ana-
lysis. Similar to the result of univariate analysis, diabetes
mellitus was not a significant predictor in the multi-
variate logistic regression model.
With respect to behavioral factors, overweight was
significantly associated with the prevalence of CVD in the
univariate analysis, but not in the multivariate analysis.
Smoking status did not show significant impact on the
prevalence of CVD in either the univariate or multivariate
analyses.
DISCUSSION
To identify the determinants of CVD for health services
planning, the present study considered the importance of
biologic and behavioral factors in CVD. The findings
indicated that hypertension, hypertriglyceridemia, low
HDL-C concentration, and overweight were significantly
associated with the prevalence of CVD among the elderly
in Taiwan according to multivariate analysis. However,
the results of multivariate analysis differ from those of uni-
variate analysis from time to time [32–34]. In this study,
gender, high LDL-C concentration, and hypercholesterol-
emia were significant predictors in the univariate analy-
sis, but did not exhibit significant influence in the multi-
variate analysis. Whether the variance in hypercholesterol-
emia and high LDL-C concentration is shared by other
variables or reduced by the problem of collinearity needs
further investigation.
Hypertension was the most significant determinant
of CVD in the present study, which is not only consistent
with the findings of previous studies [12–17,30,32], but
also extends the generalizability to the elderly popula-
tion in Taiwan. In recognition of the critical influence of
hypertension on CVD, more hypertension screening
programs should be applied in the community on a large
scale. A positive association between elevated triglycer-
ides and the prevalence of CHD has been found in many
studies [33–39]. This study suggested that high trigly-
cerides are a biologic risk factor for CVD in both uni-
variate and multivariate analyses, in which cholesterol,
LDL-C, HDL-C, and lifestyle factors were held constant.
Low HDL-C concentration was a significant risk factor
in both logistic regression models, which verified the
findings of other studies in Taiwan and other countries
[22,40].
The influence of cholesterol on the prevalence of
CVD is controversial [19,20,22,41]. In the present study,
the cholesterol level did not reach a significant level
in multivariate analysis, but it was significant in uni-
variate analysis. Several studies found that the associa-
tion between triglyceride concentration and CHD was
usually interrelated with cholesterol concentration,
except in diabetes [42]. This may explain the source of
controversy regarding the influence of cholesterol. Dia-
betes mellitus is a significant predictor in many studies
[43–46]. However, diabetes mellitus was not a signifi-
cant predictor of CVD in our study, in either univariate
or multivariate analysis, which is also indicated in other
studies in Taiwan [3,20]. Whether diabetes mellitus can
serve as a good predictor for CVD in Taiwan needs further
evaluation.
Of the behavioral factors, overweight was signifi-
cantly associated with the prevalence of CVD, which is
consistent with other studies [18,23]. Smoking beha-
vior, either heavy smoker or ex-smoker, was not an in-
fluential predictor of CVD, which is consistent with the
other studies in Taiwan [29] but different from Western
studies [47,48]. The differences between countries require
more exploration.
In conclusion, the present study confirms that hyper-
tension, hypertriglyceridemia, and low HDL-C concen-
tration are significant biologic risk factors for CVD, while
overweight is the only behavioral risk factor for CVD. These
findings not only confirm the risk factors for CVD but also
enrich the literature evidence for the elderly population.
However, the common weaknesses of cross-sectional study
design are still inevitable. In this regard, a longitudinal
study will be useful to explore cause-effect relationships
between risk factors and specific diseases.
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